Bonesupport Holding AB (OSTO:BONEX) Cyclically Adjusted Revenue per Share: kr7.56 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:BONEX Bonesupport Holding AB OSTO:BONEX
76 GF Score
Price kr220.20
GF Value kr428.72
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Bonesupport Holding AB Cyclically Adjusted Revenue per Share?

Bonesupport Holding AB OSTO:BONEX 76 Cyclically Adjusted Revenue per Share is kr7.56 as of Jun. 2026. GuruFocus rates OSTO:BONEX with a GF Score™ of 76/100 and a GF Value™ of kr428.72 (Significantly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Bonesupport Holding AB's adjusted revenue per share for the three months ended in Jun. 2026 was kr5.327. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is kr7.56 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Bonesupport Holding AB's average Cyclically Adjusted Revenue Growth Rate was 25.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-08-03), Bonesupport Holding AB's current stock price is kr220.20. Bonesupport Holding AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was kr7.56. Bonesupport Holding AB's Cyclically Adjusted PS Ratio of today is 29.13.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of Bonesupport Holding AB was 53.62. The lowest was 25.79. And the median was 31.91.


Bonesupport Holding AB  (OSTO:BONEX) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Bonesupport Holding AB's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=220.20/7.56
=29.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of Bonesupport Holding AB was 53.62. The lowest was 25.79. And the median was 31.91.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Bonesupport Holding AB Cyclically Adjusted Revenue per Share Related Terms


Bonesupport Holding AB Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Bonesupport Holding AB's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bonesupport Holding AB Cyclically Adjusted Revenue per Share Chart

Bonesupport Holding AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 6.65

Bonesupport Holding AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.05 6.34 6.65 7.07 7.56

OSTO:BONEX vs ISRG, BDX, MDLN: Cyclically Adjusted Revenue per Share Comparison

For the Medical Instruments & Supplies subindustry, Bonesupport Holding AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bonesupport Holding AB Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bonesupport Holding AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bonesupport Holding AB's Cyclically Adjusted PS Ratio falls into.


OSTO:BONEX
76GF Score
Bonesupport Holding AB OSTO:BONEX
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bonesupport Holding AB Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bonesupport Holding AB's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=5.327/134.6100*134.6100
=5.327

Current CPI (Jun. 2026) = 134.6100.

Bonesupport Holding AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.574 101.138 0.764
201612 0.641 102.022 0.846
201703 0.702 102.022 0.926
201706 0.796 102.752 1.043
201709 0.658 103.279 0.858
201712 0.538 103.793 0.698
201803 0.615 103.962 0.796
201806 0.555 104.875 0.712
201809 0.280 105.679 0.357
201812 0.447 105.912 0.568
201903 0.634 105.886 0.806
201906 0.721 106.742 0.909
201909 0.754 107.214 0.947
201912 0.888 107.766 1.109
202003 0.830 106.563 1.048
202006 0.624 107.498 0.781
202009 0.757 107.635 0.947
202012 0.850 108.296 1.057
202103 0.703 108.360 0.873
202106 0.810 108.928 1.001
202109 0.856 110.338 1.044
202112 0.958 112.486 1.146
202203 1.031 114.825 1.209
202206 1.157 118.384 1.316
202209 1.312 122.296 1.444
202212 1.600 126.365 1.704
202303 1.848 127.042 1.958
202306 2.131 129.407 2.217
202309 2.401 130.224 2.482
202312 2.608 131.912 2.661
202403 2.773 132.205 2.823
202406 3.296 132.716 3.343
202409 3.558 132.304 3.620
202412 3.846 132.987 3.893
202503 4.244 132.825 4.301
202506 4.260 133.699 4.289
202509 4.407 133.480 4.444
202512 4.681 133.390 4.724
202603 4.853 133.560 4.891
202606 5.327 134.610 5.327

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of kr7.56 mean?
Bonesupport Holding AB (OSTO:BONEX) has a Cyclically Adjusted Revenue per Share of kr7.56 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Bonesupport Holding AB and its competitors.
Is Bonesupport Holding AB's Cyclically Adjusted Revenue per Share too high?
Bonesupport Holding AB's current Cyclically Adjusted Revenue per Share is kr7.56. Overall, Bonesupport Holding AB has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bonesupport Holding AB's Cyclically Adjusted Revenue per Share compare to ISRG and BDX?
Bonesupport Holding AB's Cyclically Adjusted Revenue per Share of kr7.56 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Bonesupport Holding AB and its competitors. Bonesupport Holding AB's current Cyclically Adjusted Revenue per Share is kr7.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bonesupport Holding AB stock overvalued right now?
Based on GuruFocus' analysis, Bonesupport Holding AB (OSTO:BONEX) is currently considered Significantly Undervalued. The stock's GF Value™ is kr428.72, compared to a current price of kr220.20 — trading 48.6% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is kr7.56. Bonesupport Holding AB's overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Bonesupport Holding AB (OSTO:BONEX), the current Cyclically Adjusted Revenue per Share is kr7.56 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bonesupport Holding AB (OSTO:BONEX) Overvalued in 2026?

Based on GuruFocus' analysis, Bonesupport Holding AB stock appears to be undervalued. The current stock price of kr220.20 is trading 48.6% below its estimated GF Value™ of kr428.72. GuruFocus considers Bonesupport Holding AB to be Significantly Undervalued.

Key valuation signals for OSTO:BONEX:

  • Cyclically Adjusted Revenue per Share: kr7.56
  • GF Value™: kr428.72 vs. price of kr220.20 (48.6% below fair value)
  • GF Score™: 76/100 with 2 warning signs

No single metric tells the full story. See the OSTO:BONEX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bonesupport Holding AB Business Description

Address Scheelevagen 19, Lund, SWE, SE-223 70
Bonesupport Holding AB is a fast-growing ortho-biologics company that focuses on the treatment of bone disorders. The Company develops and commercializes injectable bio-ceramic bone graft substitutes based on its CERAMENT platform, which remodels to bone and can release pharmaceuticals to promote healing. The products of the company focus on trauma, revision arthroplasty (replacement of joint prostheses), chronic osteomyelitis (bone infection), and foot and ankle surgery. The Group manages and monitors operations in two operating segments: United States and Europe & Rest of the World (EUROW).
76GF Score

Get the complete analysis for OSTO:BONEX

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr220.20
Price
kr428.72
GF Value